PPARA and familial hypercholesterolemia: Fibrate drugs (e.g., bezafibrate, ciprofibrate, etofibrate, and gemfibrozil) are also potent activators of PPAR-α, which are used in hypercholesterolemia primarily due to their ability to substantially increase HDL levels and lower TG levels.